Hyperfine (HYPR) Expected to Announce Earnings on Tuesday

Hyperfine (NASDAQ:HYPR - Get Free Report) will likely be issuing its Q1 2025 quarterly earnings data after the market closes on Tuesday, May 13th. Analysts expect Hyperfine to post earnings of ($0.12) per share and revenue of $2.82 million for the quarter. Hyperfine has set its FY 2025 guidance at EPS.

Hyperfine (NASDAQ:HYPR - Get Free Report) last posted its quarterly earnings results on Monday, March 17th. The company reported ($0.14) EPS for the quarter, topping analysts' consensus estimates of ($0.16) by $0.02. The firm had revenue of $2.32 million during the quarter, compared to analyst estimates of $2.30 million. Hyperfine had a negative return on equity of 57.54% and a negative net margin of 309.42%. During the same period last year, the company earned ($0.15) earnings per share. On average, analysts expect Hyperfine to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Hyperfine Stock Performance

Hyperfine stock opened at $0.68 on Tuesday. Hyperfine has a fifty-two week low of $0.58 and a fifty-two week high of $1.90. The firm's fifty day moving average price is $0.79 and its 200-day moving average price is $0.94. The stock has a market cap of $53.00 million, a P/E ratio of -1.19 and a beta of 1.04.

Wall Street Analyst Weigh In

HYPR has been the topic of several recent research reports. Wells Fargo & Company increased their price target on shares of Hyperfine from $1.10 to $1.29 and gave the stock an "equal weight" rating in a research report on Tuesday, March 18th. Lake Street Capital began coverage on shares of Hyperfine in a research note on Monday, March 24th. They set a "buy" rating and a $1.50 price objective on the stock. Finally, B. Riley decreased their price objective on Hyperfine from $1.50 to $1.20 and set a "buy" rating on the stock in a report on Thursday, March 20th.

Hyperfine Company Profile

Hyperfine, Inc, a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.